Explore and identify novel biomarkers or signatures to predict disease progression and to stratify divergent phenotypes for patients with primary sclerosing cholangitis (PSC) with and without inflammatory bowel disease (IBD)

Project Details

Short titleExplore and identify novel biomarkers or signatures to predict disease progression and to stratify divergent phenotypes for patients with primary sclerosing cholangitis (PSC) with and without inflammatory bowel disease (IBD)
StatusActive
Effective start/end date1/07/20 → 30/06/23

Funding

  • BRISTOL MYERS SQUIBB PHARMACEUTICALS